文献速递妇产影像泌尿生殖儿科影像US

产前肾脏超声异常与中国大型队列中致病性拷贝数变异的关联

Association of prenatal renal ultrasound abnormalities with pathogenic copy number variants in a large Chinese cohort.
PubMed 文献 · Ultrasound Obstet Gynecol · 2022-01-01

本研究回顾性分析877例产前超声发现肾脏异常的胎儿,评估染色体微阵列分析(CMA)在不同类型肾脏异常中的诊断价值。结果显示致病性/可能致病性拷贝数变异(P/LP CNV)检出率在不同类型肾脏异常间差异显著(3.03%-39.58%),以高回声肾最高(39.58%),肾盂扩张最低(3.65%)。17q12缺失是最常见的致病性CNV,占所有阳性CMA结果的30.14%。作者建议高回声肾(无论是否孤立)应行产前CMA检测,而胎儿肾盂扩张应在出生后而非产前行CMA检测。

要点

  • 高回声肾的P/LP CNV检出率最高(39.58%),其中孤立性高回声肾为44.44%,非孤立性为25.00%。
  • 胎儿肾盂扩张最常见(34.32%),但P/LP CNV检出率仅3.65%,孤立性为2.37%,非孤立性为5.30%。
  • 17q12缺失是最常见致病性CNV,占所有阳性CMA结果的30.14%,在肾脏异常胎儿中占2.51%。

核心结论

  • 不同肾脏超声异常类型的P/LP CNV检出率差异显著(3.03%-39.58%),高回声肾检出率最高,肾盂扩张最低;作者建议高回声肾(无论是否孤立)行产前CMA检测,而胎儿肾盂扩张应在出生后而非产前行CMA检测。

研究设计与样本

  • 回顾性研究,纳入2013年1月至2019年11月在广西壮族自治区妇幼保健院常规筛查的14-36周胎儿,共877例肾脏超声异常胎儿,采用绒毛膜绒毛取样、羊膜腔穿刺或脐带穿刺获取组织行CMA分析。

诊断标准与关键数值

  • 高回声肾P/LP CNV检出率39.58%(19/48),其中孤立性44.44%(16/36),非孤立性25.00%(3/12);肾盂扩张检出率3.65%(11/301),其中孤立性2.37%(4/169),非孤立性5.30%(7/132);肾缺如检出率12.64%(11/87),其中孤立性11.54%(9/78),非孤立性22.22%(2/9),单侧11.39%(9/79),双侧25.00%(2/8);多囊性发育不良肾11.82%(n=110)、肾囊肿11.76%(n=34)、肾发育不良7.41%(n=27)、交叉融合异位肾6.45%(n=31)、肾积水6.12%(n=98)、重复肾4.76%(n=42)、异位肾3.03%(n=99)的总体诊断率分别为上述数值。

临床应用与阅片要点

  • 作者建议高回声肾(无论是否孤立)行产前CMA检测,而胎儿肾盂扩张应在出生后而非产前行CMA检测。

局限性

  • 本系列中肾脏异常诊断相对较晚,64%的孤立性肾脏异常病例接受了脐带穿刺而非绒毛膜绒毛取样。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To assess the clinical utility of prenatal chromosomal microarray analysis (CMA) in fetuses with abnormal renal sonographic findings, and to evaluate the association of pathogenic or likely pathogenic copy number variants (P/LP CNVs) with different types of renal abnormality.

METHODS: This was a retrospective study of fetuses at 14-36 weeks screened routinely for renal and other structural abnormalities at the Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region. We retrieved and analyzed data from fetuses with abnormal renal sonographic findings, examined between January 2013 and November 2019, which underwent CMA analysis using tissue obtained from chorionic villus sampling (CVS), amniocentesis or cordocentesis. We evaluated the CMA findings according to type of renal ultrasound anomaly and according to whether renal anomalies were isolated or non-isolated.

RESULTS: Ten types of renal anomaly were reported on prenatal ultrasound screening, at a mean ± SD gestational age of 24.9 ± 4.8 weeks. The anomalies were diagnosed relatively late in this series, as 64% of cases with an isolated renal anomaly underwent cordocentesis rather than CVS. Fetal pyelectasis was the most common renal ultrasound finding, affecting around one-third (34.32%, 301/877) of fetuses with a renal anomaly, but only 3.65% (n = 11) of these harbored a P/LP CNV (comprising: isolated cases, 2.37% (4/169); non-isolated cases, 5.30% (7/132)). Hyperechogenic kidney was found in 5.47% (n = 48) of fetuses with a renal anomaly, of which 39.58% (n = 19) had a P/LP CNV finding (comprising: isolated cases, 44.44% (16/36); non-isolated cases, 25.00% (3/12)), the highest diagnostic yield among the different types of renal anomaly. Renal agenesis, which accounted for 9.92% (n = 87) of all abnormal renal cases, had a CMA diagnostic yield of 12.64% (n = 11) (comprising: isolated cases, 11.54% (9/78); non-isolated cases, 22.22% (2/9); unilateral cases, 11.39% (9/79); bilateral cases, 25.00% (2/8)), while multicystic dysplastic kidney (n = 110), renal cyst (n = 34), renal dysplasia (n = 27), crossed fused renal ectopia (n = 31), hydronephrosis (n = 98), renal duplication (n = 42) and ectopic kidney (n = 99) had overall diagnostic rates of 11.82%, 11.76%, 7.41%, 6.45%, 6.12%, 4.76% and 3.03%, respectively. Compared with the combined group of CMA-negative fetuses with any other type of renal anomaly, the rate of infant being alive and well at birth was significantly higher in CMA-negative fetuses with isolated fetal pyelectasis or ectopic kidney, whereas the rate was significantly lower in fetuses with isolated renal agenesis, multicystic dysplastic kidney or severe hydronephrosis. The most common pathogenic CNV was 17q12 deletion, which accounted for 30.14% (22/73) of all positive CMA findings, with a rate of 2.51% (22/877) among fetuses with an abnormal renal finding. Fetuses with 17q12 deletion exhibited a wide range of renal phenotypes. Other P/LP CNVs in the recurrent region that were associated with prenatal renal ultrasound abnormalities included 22q11.2, Xp21.1, Xp22.3, 2q13, 16p11.2 and 1q21, which, collectively, accounted for 2.17% (19/877) of the fetuses with prenatal renal anomalies.

CONCLUSIONS: In this retrospective review of CMA findings in a large cohort of fetuses with different types of renal ultrasound abnormality, the P/LP CNV detection rate varied significantly (3.03-39.58%) among the different types of kidney anomaly. Our data may help in the decision regarding whether to perform prenatal genetic testing in fetuses with renal ultrasound findings. Specifically, prenatal CMA testing should be performed in cases of hyperechogenic kidney, regardless of whether or not the anomaly is isolated, while it should be performed postnatally rather than prenatally in cases of fetal pyelectasis. © 2021 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Su J, Qin Z, Fu H, et al. Association of prenatal renal ultrasound abnormalities with pathogenic copy number variants in a large Chinese cohort. Ultrasound Obstet Gynecol. 2022. PMID: 34090309. doi:10.1002/uog.23702

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。